U
BIND

UBS’s BIND THERAPEUTICS INC BIND Stock Holding History

UBS’s Portfolio BIND Stock Details BIND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$26K Buy
3,063
+563
+23% +$5.55K ﹤0.01% 7695
2014
Q2 		$33K Buy
2,500
+500
+25% +$4.89K ﹤0.01% 7443
2014
Q1 		$24K Buy
2,000
+400
+25% +$5.22K ﹤0.01% 7882
2013
Q4 		$24K Buy
+1,600
New +$20.4K ﹤0.01% 7945

Other funds holding BIND

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

UBS's BIND Position: Q3 2014 in Review

UBS increased its BIND THERAPEUTICS INC (BIND) stake by 23% in Q3 2014, buying an estimated $5.55K and bringing the position to 3,063 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #7695.

UBS first reported a position in BIND in Q4 2013 and has held it in 4 quarters since. The position peaked at $33K in Q2 2014. 40 funds tracked by Wall St. Rank hold BIND as of Q3 2014.

  • UBS held 3,063 shares of BIND THERAPEUTICS INC worth $26K as of Q3 2014.
  • UBS bought 563 BIND THERAPEUTICS INC shares in Q3 2014, an estimated $5.55K.
  • BIND THERAPEUTICS INC made up ﹤0.01% of UBS's portfolio in Q3 2014, its #7695 holding.
  • UBS first reported a position in BIND THERAPEUTICS INC in Q4 2013 and has held it in 4 quarters since.
  • UBS's BIND THERAPEUTICS INC position peaked at $33K in Q2 2014.
  • 40 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.